IMPAIRED LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: INSIGHTS FROM THE RELAX TRIAL
Adam D. DeVore(Duke University), Eric J. Velazquez(Yale University), Gregory D. Lewis(Brigham and Women's Hospital), Margaret M. Redfield(Mayo Clinic in Arizona), Mads Ersbøll(Duke University), Grace Lin(Mayo Clinic), Steven E. McNulty, Fawaz Alenezi(Duke University), Marc J. Semigran(Healthwise), Adrian F. Hernandez(Duke University), Jae K. Oh(Clinical Research Institute), Kevin Anstrom(PragmatIC (United Kingdom))
Cited by 30
Related Papers
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
|New England Journal of Medicine|2004|1.9k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k